Further, Ara-LAM treatment significantly reduced the parasite burden in the liver and spleen 14 and 28 days after the infection (Fig 6) accompanied with the expansion of IFN-γ+CD8+T-cells (Fig 7). This evidence concerns the gene CD8A and infection.